oxazoles has been researched along with Arteriosclerosis in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aragoncillo, P; Cachofeiro, V; Cediel, E; de las Heras, N; Lahera, V; OubiƱa, MP; Sanz-Rosa, D | 1 |
Abid, S; Grove, RI; Hartl, KS; Kowala, MC; Mazzucco, CE; Seiler, SM; Warr, GA | 1 |
Brown, KK; Glass, CK; Li, AC; Palinski, W; Silvestre, MJ; Willson, TM | 1 |
Buono, G; Cafiero, M; Rocca, G; Sensale, P | 1 |
Adamska-Dyniewska, H | 1 |
1 review(s) available for oxazoles and Arteriosclerosis
Article | Year |
---|---|
[Clinical study of the effectivesness of 2 drugs with action against platelet aggregation].
Topics: Arteriosclerosis; Humans; In Vitro Techniques; Oxazoles; Phosphatidylcholines; Platelet Adhesiveness; Platelet Aggregation; Thrombosis | 1975 |
4 other study(ies) available for oxazoles and Arteriosclerosis
Article | Year |
---|---|
Comparison between the effects of mixed dyslipidaemia and hypercholesterolaemia on endothelial function, atherosclerotic lesions and fibrinolysis in rabbits.
Topics: Acetylcholine; Animals; Aorta; Arteriosclerosis; Bridged Bicyclo Compounds, Heterocyclic; Diet; Endothelium, Vascular; Enzyme Inhibitors; Fibrinolysis; Hypercholesterolemia; Hyperlipidemias; Hypertriglyceridemia; In Vitro Techniques; Male; Models, Animal; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxazoles; Plasminogen Activator Inhibitor 1; Rabbits; Thromboxane A2; Tissue Plasminogen Activator; Vasoconstrictor Agents | 2003 |
Prostacyclin agonists reduce early atherosclerosis in hyperlipidemic hamsters. Octimibate and BMY 42393 suppress monocyte chemotaxis, macrophage cholesteryl ester accumulation, scavenger receptor activity, and tumor necrosis factor production.
Topics: Animals; Aorta, Thoracic; Arteriosclerosis; Chemotaxis; Cholesterol Esters; Cricetinae; Epoprostenol; Hyperlipidemias; Imidazoles; Macrophages; Male; Membrane Proteins; Monocytes; Oxazoles; Phenoxyacetates; Receptors, Immunologic; Receptors, Lipoprotein; Receptors, Scavenger; Scavenger Receptors, Class B; Tumor Necrosis Factor-alpha | 1993 |
Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice.
Topics: Animals; Arteriosclerosis; Base Sequence; CD36 Antigens; DNA Primers; Female; Gene Expression; Humans; Insulin Resistance; Ligands; Male; Matrix Metalloproteinase 9; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxazoles; Receptors, Cytoplasmic and Nuclear; Receptors, Immunologic; Receptors, LDL; Receptors, Lipoprotein; Receptors, Scavenger; RNA, Messenger; Rosiglitazone; Scavenger Receptors, Class B; Thiazoles; Thiazolidinediones; Transcription Factors; Tumor Necrosis Factor-alpha; Tyrosine | 2000 |
[Use of dantromin in geriatrics].
Topics: Aged; Arteriosclerosis; Basal Metabolism; Blood Pressure; Central Nervous System Stimulants; Humans; Middle Aged; Oxazoles; Pemoline | 1967 |